However, pretreatment of the tumor cells with IFNγ did not lead to increased responsiveness to checkpoint treatment; thus, the effect was not fully explained by increased MHC class I on the tumor cells, but rather activation of a broad range of immune cells. Here, IFNG is linked to neoplasm.